Related Experiment Video

Updated: Jun 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Current epidemiology of Pneumocystis jirovecii infections]

Elzbieta Gołab1

  • 1Zakład Parazytologii Lekarskiej, Narodowy Instytut Zdrowia Publicznego-Państwowy Zakład Higieny. egolab@pzh.gov.pl

Przeglad Epidemiologiczny
|November 11, 2009
PubMed

Insights

Pneumocystis pneumonia (PCP) is caused by Pneumocystis fungi. This review examines the changing epidemiology and transmission of Pneumocystis jirovecii in both immunocompromised and immunocompetent individuals, including data from Poland.

Area of Science:

  • Medical Mycology
  • Infectious Diseases Epidemiology

Background:

  • Pneumocystis fungi are known causes of pneumonia, particularly in immunocompromised individuals.
  • The epidemiology of Pneumocystis infections has evolved significantly over the last 20 years.

Purpose of the Study:

  • To review the current understanding of factors influencing the spread of Pneumocystis jirovecii.
  • To discuss primary infections, transmission routes, and colonization.
  • To present data on P. jirovecii infections specifically within Poland.

Main Methods:

  • Literature review focusing on Pneumocystis jirovecii epidemiology.
  • Analysis of factors contributing to infection spread.
  • Inclusion of regional epidemiological data.

Main Results:

  • Highlights key factors driving Pneumocystis jirovecii transmission.
  • Discusses primary infection dynamics and colonization.
  • Presents specific epidemiological data for Poland.

Conclusions:

  • Understanding Pneumocystis jirovecii transmission is crucial for public health.
  • The review synthesizes current knowledge on Pneumocystis epidemiology.
  • Regional data provides valuable insights into infection patterns.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: